Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.
Anticancer Drugs. 2005 Oct;16(9):1023-8. doi: 10.1097/01.cad.0000176508.73090.fb.
Anticancer Drugs. 2005.
PMID: 16162980
Clinical Trial.
Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study.
Rupp U, Schoendorf-Holland E, Eichbaum M, Schuetz F, Lauschner I, Schmidt P, Staab A, Hanft G, Huober J, Sinn HP, Sohn C, Schneeweiss A.
Rupp U, et al. Among authors: lauschner i.
Anticancer Drugs. 2007 Apr;18(4):477-85. doi: 10.1097/CAD.0b013e32801403f4.
Anticancer Drugs. 2007.
PMID: 17351401
Clinical Trial.
Item in Clipboard
Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trial.
Schneeweiss A, Lauschner I, Ruiz A, Guerrero A, Sánchez-Rovira P, Seguí MA, Goerke K, Wolf M, Manikhas AG, Wacker J, Marmé F, Lichter P, Sinn HP, Sohn C, Mansouri K, Bauknecht T, Hahn M.
Schneeweiss A, et al. Among authors: lauschner i.
Clin Breast Cancer. 2007 Apr;7(7):555-8. doi: 10.3816/CBC.2007.n.011.
Clin Breast Cancer. 2007.
PMID: 17509164
Clinical Trial.
Item in Clipboard
Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Eichbaum MH, Schuetz F, Khbeis T, Lauschner I, Foerster F, Sohn C, Schneeweiss A.
Eichbaum MH, et al. Among authors: lauschner i.
Anticancer Drugs. 2007 Sep;18(8):963-8. doi: 10.1097/CAD.0b013e328165d11a.
Anticancer Drugs. 2007.
PMID: 17667603
Clinical Trial.
Item in Clipboard
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.
Schneeweiss A, Diel I, Hensel M, Kaul S, Sinn HP, Unnebrink K, Rudlowski C, Lauschner I, Schuetz F, Egerer G, Haas R, Ho AD, Bastert G.
Schneeweiss A, et al. Among authors: lauschner i.
Ann Oncol. 2004 Nov;15(11):1627-32. doi: 10.1093/annonc/mdh433.
Ann Oncol. 2004.
PMID: 15520063
Free article.
Item in Clipboard
Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapy.
Schneeweiss A, Goerner R, Hensel MA, Lauschner I, Sinn P, Kaul S, Egerer G, Beldermann F, Geberth M, Solomayer E, Grischke EM, Haas R, Ho AD, Bastert G.
Schneeweiss A, et al. Among authors: lauschner i.
Biol Blood Marrow Transplant. 2001;7(6):332-42. doi: 10.1016/s1083-8791(01)80004-5.
Biol Blood Marrow Transplant. 2001.
PMID: 11464976
Free article.
Item in Clipboard
Cite
Cite